Benign myoepithelial tumors of the breast have immunophenotypic characteristics similar to metaplastic matrix-producing and spindle cell carcinomas

American Journal of Clinical Pathology

Volumn 120, Issue 2, 2003, Pages 161-167

  Popnikolov, Nikolay K ^a,d   Ayala, Alberto G ^b   Graves, Kerry ^a   Gatalica, Zoran ^c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^d GRADUATE HOSPITAL   (United States)

Author keywords

Adenomyoepithelioma; Breast; Metaplastic carcinoma; Myoepithelial cells

Indexed keywords

ACTIN; ALPHA SMOOTH MUSCLE ACTIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; MASPIN; MYOSIN; PROTEIN P53; PROTEIN S 100; STEROID RECEPTOR; UNCLASSIFIED DRUG; VIMENTIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; MYOEPITHELIOMA; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINDLE CELL CARCINOMA; BREAST TUMOR; CARCINOMA; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; EPITHELIUM CELL; METABOLISM; METAPLASIA; MIDDLE AGED; MUSCLE CELL; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; METAPLASIA; MIDDLE AGED; MUSCLE CELLS; MYOEPITHELIOMA; NEOPLASM PROTEINS; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 85047687604     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/G6CTR8MDTFUW19XV     Document Type: Article

References (41)

1. Tavassoli FA. Miscellaneous lesions. In: Pathology of the Breast. 2nd ed. New York, NY: McGraw-Hill; 1999:763-827.
2. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast, III: carcinosarcoma. Cancer. 1989;64:1490-1499.
3. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast, I: matrix-producing carcinoma. Hum Pathol. 1989;20:628-635.
4. Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. Edinburgh, Scotland: Churchill Livingstone; 1990.
5. Tavassoli FA. Pathology of the Breast. 2nd ed. New York, NY: McGraw-Hill; 1999.
6. Rosen PP. Rosen's Breast Pathology. 2nd ed. Philadelphia, PA: Lippincott-Williams & Wilkins; 2001.
7. Shipp MA, Look AT. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood. 1993;82:1052-1070.
8. Harrison NK, Daves KE, Kwon OJ, et al. Effect of neuropeptides on normal lung fibroblast proliferation and chemotaxis. Am J Physiol. 1995;268:L278-L283.
9. Sumitomo M, Shen R, Walburg M, et al. Neutral endopeptidase inhibits prostate cancer migration by blocking focal adhesion kinase signaling. J Clin Invest. 2000;106:1399-1407.
10. Cutrona G, Leanza N, Ulivi M, et al. Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo. Blood. 1999;94:3067-3076.
11. Ganju RK, Shpector RG, Brenner DG, et al. CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase 11 and coassociated with other phosphoproteins including the lyn src-related kinase. Blood. 1996;88:4159-4165.
12. Pechoux C, Gudjonsson T, Ronnov-Jessen L, et al. Human mammary luminal epithelial cells contain progenitors to myoepithelial cells. Dev Biol. 1999;206:88-99.
13. Koyama M, Kurotaki H, Yagihashi N, et al. Immunohistochemical assessment of proliferative activity in mammary adenomyoepithelioma. Histopathology. 1997;31:134-139.
14. Loose JH, Patchefsky AS, Hollander IJ, et al. Adenomyoepithelioma of the breast: a spectrum of biologic behavior. Am J Surg Pathol. 1992;16:868-876.
15. Sileikiene D, Gupta D, Qi J, et al. Adenomyoepithelioma of the breast: a cytohistologic and immunohistochemical study of 17 cases [abstract]. Mod Pathol. 2001;14:37A.
16. Tamura S, Enjoji M, Toyoshima S, et al. Adenomyoepithelioma of the breast: a case report with immunohistochemical study. Acta Pathol Jpn. 1988;659-665.
17. Tavassoli FA. Myoepithelial lesions of the breast: myoepitheliosis, adenomyoepithelioma, and myoepithelial carcinoma. Am J Surg Pathol. 1991;15:554-568.
18. Ballance WA, Ro JY, El-Naggar AK, et al. Pleomorphic adenoma (benign mixed tumor) of the breast: an immunohistochemical, flow cytometric, and ultrastructural study and review of the literature. Am J Clin Pathol. 1990;93:795-801.
19. Betta PG, Spinoglio G. Benign mixed salivary-type tumor of the breast. Eur J Surg Oncol. 1992;18:304-306.
20. Diaz NM, McDavid RW, Wick M. Pleomorphic adenoma of the breast: a clinicopathologic and immunohistochemical study of 10 cases. Hum Pathol. 1991;22:1206-1214.
21. Moran CA, Suster S, Carter D. Benign mixed tumors (pleomorphic adenomas) of the breast. Am J Surg Pathol. 1990;14:913-921.
22. Stingl J, Eaves CJ, Kuusk U, et al. Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation. 1998;63:201-213.
23. Rosen PP. Myoepithelial neoplasms. In: Rosen's Breast Pathology. 2nd ed. Philadelphia, PA: Lippincott-Williams & Wilkins; 2001:121-138.
24. Segen JC, Foo M, Richer S. Pleomorphic adenoma of the breast with positive estrogen receptors. N Y State J Med. 1986;86:265-266.
25. Willen R, Uvelius B, Cameron R. Pleomorphic adenoma in the breast of a human female: aspiration biopsy findings and receptor determination: case report. Acta Chir Scand. 1986;152:709-713.
26. Ellis IO, Bell J, Ronan JE, et al. Immunohistochemical investigation of intermediate filament proteins and epithelial membrane antigen in spindle cells tumors of the breast. J Pathol. 1988;154:157-165.
27. Gobbi H, Simpson JF, Borowsky RA, et al. Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence. Cancer. 1999;85:2170-2182.
28. Oberman HA. Metaplastic carcinoma of the breast: a clinicopathologic study of 29 patients. Am J Surg Pathol. 1987;11:918-929.
29. Raju GC, Wee A. Spindle cell carcinoma of the breast. Histopathology. 1990;16:497-499.
30. Heatley M, Whiteside C, Maxwell P, et al. Vimentin expression in benign and malignant breast epithelium. J Clin Pathol. 1993;46:441-445.
31. Meis JM, Ordonez NG, Gallager HS. Sarcomatoid carcinoma of the breast: an immunohistochemical study of six cases. Virchows Arch A Pathol Anat Histopathol. 1987;410:415-421.
32. Sexton CW, White WL. Chondrosarcomatous cutaneous metastasis: a unique manifestation of sarcomatoid (metaplastic) breast carcinoma. Am J Dermatopathol. 1996;18:538-542.
33. Sneige N, Yaziji H, Mandavilli S, et al. Low-grade (fibroma-like) spindle cell carcinomas of the breast. Am J Surg Pathol. 2001;25:1009-1016.
34. Zhang PJ, Nolan C, Driscoll DL, et al. Maspin a prognostic marker for breast cancer [abstract]? Mod Pathol. 1998;11:31A.
35. Lele SM, Graves K, Gatalica Z. Immunohistochemical detection of maspin is useful adjunct in distinguishing radial sclerosing lesions from tubular carcinoma of the breast. Appl Immunohistochem Molecul Morphol. 2000;8:32-36.
36. Maas N, Hojo T, Zhang M, et al. Maspin: a novel protease inhibitor with tumor-suppressing activity in breast cancer. Acta Oncol. 2000;39:931-934.
37. Sheng S, Carey J, Seftor EA, et al. Maspin acts at the cell membrane to inhibit invasion and motility of the mammary and prostatic cancer cells. Proc Natl Acad Sci U S A. 1996;93:11669-11674.
38. Zou Z, Anisowic A, Hendrix MJ, et al. Identification of novel serpin with tumor suppressing activity in human mammary epithelial cells. Science. 1994;263:526-529.
39. Zhang M, Volpert O, Shi YH, et al. Maspin is an angiogenesis inhibitor. Nature Med. 2000;6:196-199.
40. Chhieng C, Cranor M, Lesser ME, et al. Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements. Am J Surg Pathol. 1998;22:188-194.
41. Barsky SH, Shanmugasundaram G, Wu D. Metaplastic carcinomas, matrix-producing type (matrix-producing carcinomas) of the breast exhibit a myoepithelial histogenesis [abstract]. Mod Pathol. 2003;16:23A.